Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study.

Idafang (ivonescimab) - Summit Therapeutics

Avastin (bevacizumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42703567

Chun Huang; Dingzhi Huang; Jianxi Zhou; Kang Wen; Mengjie Li; Peng Chen; Tingting Qin; Yinghao Wang; Yudong Su; Yunchuan Sun

Sep 8, 2026